This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Mannheim Gmbh. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: Barbara Prinz - Innovator in Molecular Biology
Introduction
Barbara Prinz is a distinguished inventor based in Friedrichshafen, Germany. She has made significant contributions to the field of molecular biology, particularly through her work on restriction endonucleases. Her innovative research has led to the development of a novel enzyme that has important applications in genetic engineering.
Latest Patents
Barbara Prinz holds a patent for the Type II restriction endonuclease SwaI. This enzyme has a specific recognition sequence and is known for its ability to cleave DNA at designated sites. The SwaI enzyme is preferably obtained from microorganisms of the genus Staphylococcus, showcasing the intersection of microbiology and genetic research.
Career Highlights
Throughout her career, Barbara has been associated with Boehringer Mannheim GmbH, where she has contributed to various research projects. Her work has not only advanced scientific understanding but has also paved the way for practical applications in biotechnology.
Collaborations
Barbara has collaborated with notable colleagues, including Bruno Frey and Max Lechner. These partnerships have enriched her research and expanded the impact of her innovations in the scientific community.
Conclusion
Barbara Prinz is a remarkable inventor whose work in developing the SwaI restriction endonuclease exemplifies the importance of innovation in molecular biology. Her contributions continue to influence the field and inspire future research.